113 related articles for article (PubMed ID: 22132974)
1. Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.
Saiko P; Graser G; Madlener S; Schwarz S; Krupitza G; Jaeger W; Somepalli V; Golakoti T; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1190-6. PubMed ID: 22132974
[TBL] [Abstract][Full Text] [Related]
2. Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.
Saiko P; Graser G; Giessrigl B; Steinmann MT; Schuster H; Lackner A; Grusch M; Krupitza G; Jaeger W; Somepalli V; Golakoti T; Fritzer-Szekeres M; Szekeres T
Invest New Drugs; 2013 Oct; 31(5):1115-24. PubMed ID: 23943154
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
[TBL] [Abstract][Full Text] [Related]
4. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
Lech-Maranda E; Korycka A; Robak T
Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
[TBL] [Abstract][Full Text] [Related]
5. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
Bernhaus A; Ozsvar-Kozma M; Saiko P; Jaschke M; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Invest New Drugs; 2009 Oct; 27(5):393-401. PubMed ID: 18841326
[TBL] [Abstract][Full Text] [Related]
7. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
Ross DD; Cuddy DP
Biochem Pharmacol; 1994 Oct; 48(8):1619-30. PubMed ID: 7980627
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.
Heinemann V; Hertel LW; Grindey GB; Plunkett W
Cancer Res; 1988 Jul; 48(14):4024-31. PubMed ID: 3383195
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
Bouffard DY; Momparler LF; Momparler RL
Anticancer Drugs; 1991 Feb; 2(1):49-55. PubMed ID: 1958852
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
Vrana JA; Kramer LB; Saunders AM; Zhang XF; Dent P; Povirk LF; Grant S
Biochem Pharmacol; 1999 Jul; 58(1):121-31. PubMed ID: 10403525
[TBL] [Abstract][Full Text] [Related]
11. Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.
Tiefenthaler M; Hohla F; Strasser-Wozak E; Bacher N; Mühlmann O; Wein W; Konwalinka G
Stem Cells; 2003; 21(3):266-71. PubMed ID: 12743321
[TBL] [Abstract][Full Text] [Related]
12. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.
Bernhaus A; Fritzer-Szekeres M; Grusch M; Saiko P; Krupitza G; Venkateswarlu S; Trimurtulu G; Jaeger W; Szekeres T
Cancer Lett; 2009 Feb; 274(2):299-304. PubMed ID: 18952370
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
Bianco C; Giovannetti E; Ciardiello F; Mey V; Nannizzi S; Tortora G; Troiani T; Pasqualetti F; Eckhardt G; de Liguoro M; Ricciardi S; Del Tacca M; Raben D; Cionini L; Danesi R
Clin Cancer Res; 2006 Dec; 12(23):7099-107. PubMed ID: 17145834
[TBL] [Abstract][Full Text] [Related]
14. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
Arumugam T; Ramachandran V; Logsdon CD
J Natl Cancer Inst; 2006 Dec; 98(24):1806-18. PubMed ID: 17179482
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells.
Tomimaru Y; Eguchi H; Wada H; Tomokuni A; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Mori M; Doki Y; Nagano H
Int J Oncol; 2011 May; 38(5):1237-43. PubMed ID: 21347515
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer.
Blaauboer A; Booy S; van Koetsveld PM; Karels B; Dogan F; van Zwienen S; van Eijck CHJ; Hofland LJ
BMC Cancer; 2020 Sep; 20(1):913. PubMed ID: 32967656
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR
Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997
[TBL] [Abstract][Full Text] [Related]
18. Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancreatic cancer cells.
Akasaka H; Sasaki R; Yoshida K; Takayama I; Yamaguchi T; Yoshida H; Mizushina Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2517-25. PubMed ID: 23174220
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models.
Merriman RL; Hertel LW; Schultz RM; Houghton PJ; Houghton JA; Rutherford PG; Tanzer LR; Boder GB; Grindey GB
Invest New Drugs; 1996; 14(3):243-7. PubMed ID: 8958178
[TBL] [Abstract][Full Text] [Related]
20. Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
Ban J; Weber G
Biochem Biophys Res Commun; 1992 Apr; 184(2):551-9. PubMed ID: 1349474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
